KRAS-IN-49
KRAS-IN-49 (compound 7b) is a selective and covalent KRAS G13C inhibitor. KRAS-IN-49 covalently binds to Cys13 of KRAS G13C. KRAS-IN-49 can be used for non-small cell lung cancer (NSCLC) research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C19H27N7O13P2
- Molecular Weight:623.40
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
KRAS G13C |
Chemical Information
-
Molecular Weight 623.40
-
Formel C19H27N7O13P2
-
SMILES
O=C1C(N=CN2[C@H]3[C@H](OC(N4CCC[C@@H](NC(C=C)=O)C4)=O)[C@H](O)[C@@H](COP(OP(O)(O)=O)(O)=O)O3)=C2N=C(N)N1.O=C5C(N=CN6[C@H]7[C@H](O)[C@H](OC(N8C[C@@H](CCC8)NC(C=C)=O)=O)[C@@H](COP(OP(O)(O)=O)(O)=O)O7)=C6N=C(N)N5
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
KRAS-IN-49 Related Classifications
HY-179536 Related Classifications
Powered by Bioz